GSK Announces Dr Jeannie Lee to Join the Board as Non-Executive Director
March 01, 2024
March 01, 2024
LONDON, England, March 1 -- GlaxoSmithKline, a biopharmaceutical company, issued the following news release on Feb. 29, 2024:
GSK plc (LSE/NYSE: GSK) has today announced that Dr Jeannie Lee has been appointed to the Board of the Company as a Non-Executive Director. Jeannie will join the Board on 4 March 2024.
Jeannie is currently the Phillip A. Sharp, PhD, Endowed Chair in Molecular Biology and Acting Chair of the Department of Molecular Biology at the Massachusetts Gen . . .
GSK plc (LSE/NYSE: GSK) has today announced that Dr Jeannie Lee has been appointed to the Board of the Company as a Non-Executive Director. Jeannie will join the Board on 4 March 2024.
Jeannie is currently the Phillip A. Sharp, PhD, Endowed Chair in Molecular Biology and Acting Chair of the Department of Molecular Biology at the Massachusetts Gen . . .